AbbVie sustainability score: 37/100
AbbVie is a US-based pharmaceutical company spun off from Abbott Laboratories in 2013 and headquartered in North Chicago. It employs approximately 57,000 people and generated US$61.2 billion in net revenues in 2025.
More about AbbVie
The company develops therapies in oncology, immunology, virology, and other areas.
Founded 2012Head office North Chicago, United StatesStaff ~57,000 (FY2025)Revenue US$61,160M net revenues (FY2025)Website ↗
AbbVie has quantified Scope 1 and 2 emissions with third-party assurance, but Scope 3 remains unmeasured across a global pharmaceutical supply chain. Scope 1 is flat; the 39% Scope 1+2 reduction relies almost entirely on renewable electricity certificates. Nature impact, Scope 3 reduction targets, and long-term net-zero validation are absent.
AbbVie scores 37/100 (Below expectations) on SINK's independent climate assessment, scored from public data only. Scores are free. Companies can never pay for anything about their own score. Last verified November 2026.
That places AbbVie joint 482nd of 934 companies scored, and joint 18th of 22 in Healthcare / Pharmaceuticals.
What is AbbVie doing well, and where does it fall short?
Strongest on Carbon Footprint: Operations and Controversies & Red Flags (8/10, 8/10). Weakest on Carbon Footprint: Supply Chain and Nature & Biodiversity Impact (3/10, 3/10).
Where AbbVie lost points
For each question that lost points, the evidence our public rubric looks for that we didn't find.
- Emissions from its own operations8/10No verified figures published with their method and a falling trend.
- Emissions from its supply chain3/10No assessment of where its supply-chain emissions come from.
- Whether its emissions are falling5/10No evidence of a year-on-year fall in its total emissions.
- How clean its energy is5/10Less than half its energy shown to be renewable, or no transition plan.
- Its effect on nature3/10No assessment of its effect on nature, and no basic environmental policy.
- How it uses materials and handles waste5/10No measurable waste or recycling targets reported publicly.
- Its effect on water6/10No water stewardship programme or verified fall in water use.
- Its climate targets7/10Its targets aren't validated by the Science Based Targets initiative.
- How openly it reports7/10No annual impact report, or no pay linked to climate targets.
A score changes when the evidence does. We use new published evidence at the next rescore. Anyone can send us new evidence, free. How to send it.
How is AbbVie's SINK score calculated?
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × ScaleHas AbbVie's score changed?
AbbVie's score has moved from 48 to 37 across 2 recorded reviews, down 11 points.
- 48 → 37-113 November 2026
Agent-mode re-score: no Scope 3 is published, so 0.70x applies; the trade-association -2 is removed because LobbyMap does not name AbbVie's membership.
- Scored 484 April 2026
Initial score at platform launch
What evidence is AbbVie's score based on?
9 sources used in this assessment. All publicly available. Each row shows which of the ten questions it informed.
11% of them were published by AbbVie itself; the rest come from independent sources.
“AbbVie's capital expenditures for pollution control in 2025 were approximately $17 million”
“we have achieved a 32.4% reduction as of 2024.”
“Increased our active sourcing of renewable electricity by 55% compared to our 2021 baseline, more than halfway to our 2030 target of 100%”
“member of the U.S. Chamber of Commerce which has consistently lobbied to roll back climate”
“AbbVie Pharmaceuticals 58,054 20k to 100k California 2012 Targets Set 1.5°C”
“16.7% in Nature Benchmark”
“Wir wollen eine Oase für Tierarten im städtischen Umfeld sein”
“Current Parent Company : AbbVie”
If you believe a source has been misread or a newer version exists, submit a challenge.
Is this your company? Claim this profile (free)
Use this score in tenders
Send the link, or the one-page score sheet. It links back to this page and every source. Free.
Open the score sheet →Send new evidence, free
Scored low because little is published? Publish what you do and send us the link, free. If it holds up, your score changes, and the change is logged on your page.
How to send evidence →Put your score on your website, free
It shows the current score and links to this page, so it changes when the score does.
Track this score
Bidding for a public contract? Check if you need a Carbon Reduction Plan, free →
Want your own page like this?
Free, independent, every source shown. Send it to any buyer who asks about your sustainability.
How does AbbVie compare with other healthcare / pharmaceuticals companies?
Where AbbVie sits among healthcare / pharmaceuticals peers.
Among the 22 major healthcare / pharmaceuticals brands we've scored, AbbVie is tied =18th of 22, with 2 others.
Who scores higher in Healthcare / Pharmaceuticals?
The 3 companies in the sector scoring nearest above AbbVie.
Merck reports emissions via GHG Protocol with third-party assurance, but buries specific figures in CDP filings.
See the breakdown →Pfizer discloses robust climate data with GHG Protocol alignment and SBTi validation, but progress is dire: only 15% of its 46% emissions reduction target achieved by 2024, renewable energy stuck at 14% despite RE100 membership, and hazardous waste flat since 2022.
See the breakdown →J&J's Scope 1 and 2 emissions fell 38% from 2021, mostly through renewable electricity instruments including unbundled certificates; Scope 1 itself fell only about 3% from 2023 to 2025.
See the breakdown →Which companies moved this week, and why.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
We'll send one email to confirm. No spam. Unsubscribe in one click.
Checking a company?
Search free →Asked to prove you're sustainable?
Get your business scored, free →Been scored?
Find your page and claim it, free →Scores are free. Companies can never pay for anything about their own score.